Home LiteratureArticle Details
PMID: 10462059 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

Discovery and characterization of endogenous cannabinoids.

Life sciences ·Vol. 65 ·No. 6-7 ·1999-00-00 ·Pages 573-95

Martin BR, Mechoulam R, Razdan RK

Abstract

The characterization of cannabinoid receptors and signal transduction mechanisms provided the impetus for the searching for endogenous ligands for this system. The result was a family of fatty acid derivatives that interact with cannabinoid receptors to varying degrees. The two ligands that have received the most attention are anandamide (AN) and 2-arachidonolyl-glycerol (Ara-Gl). They are both present in central as well as peripheral tissues. Mechanisms for the synthesis and metabolism of AN have been described. Presently, the physiological stimuli for production and release of AN are unknown. As a result, elucidation of its physiological role remains elusive. However, it seems reasonable to conclude that both AN and 2-Ara-Gl interact with cannabinoid receptors in both peripheral and central tissue to produce a wide range of effects. Administration of these ligands to laboratory animals produce effects that are quite similar to those elicited by delta9-tetrahydrocannabinol (THC), the psychoactive constituent in marijuana. Nevertheless, there are some pharmacological differences between the plant-derived THC and the endogenous cannabinoids that could be due to either pharmadynamic or pharmacokinetics dissimilarities. Extensive structure-activity relationship studies have provided some vital insights into the actions of the endogenous ligands. First and foremost, systematic structural alterations in AN have additional support that it is acting at the cannabinoid receptors in a fashion similar to that of THC. Development of metabolically stable analogs of AN, as well as those with greater receptor affinity, have helped substantiate AN and THC similarities. Nevertheless, pharmacological differences remain between the endogenous and exogenous ligands. Whether these differences are due to the nature of their interaction with the cannabinoid receptors, activation of unique signaling pathways, interactions with non-cannabinoid receptors, or pharmacokinetic considerations remain to be resolved.

MeSH Terms
Arachidonic Acids/analysis,chemistry,pharmacology Cannabinoids/chemistry,metabolism,pharmacology Endocannabinoids Glycerides/analysis,chemistry,pharmacology Humans Ligands Polyunsaturated Alkamides Receptors, Cannabinoid Receptors, Drug Signal Transduction Structure-Activity Relationship Tissue Distribution
Chemicals
Arachidonic Acids Cannabinoids Endocannabinoids Glycerides Ligands Polyunsaturated Alkamides Receptors, Cannabinoid Receptors, Drug glyceryl 2-arachidonate anandamide
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Martin B R
Virginia Commonwealth University, Richmond 23298-0613, USA.
Mechoulam R
Razdan R K
Article Info
Journal
Life sciences
Abbr.
Life Sci
ISSN
0024-3205
Published
1999-00-00
Pages
573-95
Language
English
Region
Netherlands
NLM ID
0375521
Subset
IM
Grants
NIDA NIH HHS · DA-09789 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com